Enterprise
Pricing
Explore API
Get a demo
Get started
Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
Samsung Bioepis

August 2026

Samsung Bioepis Market Share Analysis for August 2026

Samsung Bioepis is a biopharmaceutical company focused on increasing patient access to high-quality medicines through the development of biosimilars.
Health > Biotechnology and Pharmaceuticals
Domainsamsungbioepis.com
Year Founded2012
Employees501 - 1000
Annual Revenue$500M - $1B
HQ:Korea, Republic of, Yeonsu-gu
samsungbioepis.com
Samsung Bioepis
Samsung Bioepis (including company regionals)
  • samsungbioepis.com
    samsungbioepis.com
See more website traffic and engagement information

Samsung Bioepis Revenue up to August 2026 is 500M - 1B

revenue generated by Samsung Bioepis top domains

Samsung Bioepis top domains revenue over 3 years

Revenue for Samsung Bioepis top domains

samsungbioepis.comsamsungbioepis.com500M - 1B
See more with Sales Intelligence

Total visits to Samsung Bioepis's top domains

Understand Samsung Bioepis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown
samsungbioepis.comsamsungbioepis.com15.1K
See more with Sales Intelligence

Avg. visit duration in Samsung Bioepis's top domains

Analyze Samsung Bioepis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
samsungbioepis.comsamsungbioepis.com00:00:36
See more with Sales Intelligence

Avg. pageviews on Samsung Bioepis's top domains

See how Samsung Bioepis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
samsungbioepis.comsamsungbioepis.com3.26
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.

Samsung Bioepis top competitors by domain

Top similar sites in August 2026, ranked by their affinity

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.

Top technologies used by Samsung Bioepis

These are the website technologies, by industry, used by Samsung Bioepis top domains

Advertising (4)

Google Adsense

Google Adsense

See all

Conversion & Analytics (3)

Google Analytics

Google Analytics

See all

Mobile (2)

Meta Viewport

Meta Viewport

See all

Audio Video Media (1)

YouTube

YouTube

More Technologies

5

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.

News & Signals from Samsung Bioepis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSamsung Bioepis launched OPUVIZ 40 mg/mL solution in pre-filled syringe on Aug 10th '26.INCHEON, Korea - August 10, 2026 - Samsung Bioepis Co., Ltd. today announced the launch of OPUVIZ(TM) 40 mg/mL solution in pre-filled syringe (PFS), a biosimilar referencing Eylea[1] (aflibercept), across Europe, starting today.
August 10, 2026Read More
NewsSamsung Bioepis had revenue of $583M on Apr 1st '26.Samsung Bioepis, a 100% owned subsidiary of Samsung Epis Holdings, recorded revenue of 847.1 billion KRW and an operating profit of 230.6 billion KRW in the first half of 2026.
July 24, 2026Read More
NewsSamsung Bioepis had earnings of $159M on Apr 1st '26.* Samsung Bioepis reports revenue of 847.1 billion KRW and an operating profit of 230.6 billion KRW in the first half of 2026, recording 6% year-over-year growth
July 24, 2026Read More

See all Samsung Bioepis signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.